Patients
BAROSTIM THERAPY for Heart Failure

Are heart failure symptoms impacting your life? You are not alone. Millions of people worldwide suffer from these life-altering symptoms. BAROSTIM THERAPY is an effective solution to safely reduce symptoms of heart failure.
Learn More

BAROSTIM NEO and You

BAROSTIM NEO is proven to safely reduce symptoms of heart failure.
Learn More

Patient Stories

Real stories from patients that have asked if the BAROSTIM NEO is right for them.
Learn More
Healthcare Professionals
Heart Failure Trial Results

BAROSTIM NEO addresses a significant unmet medical need in the treatment of heart failure.
Learn More

About BAROSTIM NEO

BAROSTIM NEO is an implantable device that is clinically proven to safely reduce symptoms of heart failure.
Learn More

Publications

CVRx is committed to the continued publication of clinical evidence supporting the benefit of BAROSTIM THERAPY for the treatment of heart failure.
Learn More

Reimbursement

CVRx provides full BAROSTIM THERAPY Patient Access Program support to all providers.
Learn More

Medical Education

Learn more about BAROSTIM THERAPY clinical evidence, patient selection and implant procedure from the experts.
Learn More

Clinical Research

CVRx is committed to the generation of clinical evidence, including investigator-sponsored research, to support the adoption and access to our therapies.
Learn More
About Us
Our Company

CVRx® is a leader in innovative technologies that address the unmet needs in cardiovascular diseases with safe and effective therapies.
Learn More

Our Team

We are proud of our reputation for attracting some of the brightest leaders in the medical technology industry.
Learn More

Newsroom

Latest press releases and company statements.
Learn More

Resources

Downloads are made available to provide background information about us, our products and the conditions they treat.
Learn More
Investors
Contact Us

Published in JACC: Heart Failure

HOPE4HF Phase II Clinical Study Results

Baroreflex Activation Therapy for the Treatment of Heart Failure with a Reduced Ejection Fraction

See the Article

This presentation accompanied the article published in JACC: Heart Failure.

See the Presentation

HOPE4HF Phase II Clinical Study Results

Ready to learn more about Barostim?